- Home
- VTVT vs SCNX Comparison
VTVT vs SCNX Comparison
Compare VTVT & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTVT
- SCNX
- Stock Information
- Founded
- VTVT 2015
- SCNX 2010
- Country
- VTVT United States
- SCNX United States
- Employees
- VTVT N/A
- SCNX N/A
- Industry
- VTVT Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- VTVT Health Care
- SCNX Health Care
- Exchange
- VTVT Nasdaq
- SCNX Nasdaq
- Market Cap
- VTVT 38.8M
- SCNX 33.6M
- IPO Year
- VTVT 2015
- SCNX 2020
- Fundamental
- Price
- VTVT $20.20
- SCNX $2.80
- Analyst Decision
- VTVT Strong Buy
- SCNX
- Analyst Count
- VTVT 1
- SCNX 0
- Target Price
- VTVT $35.00
- SCNX N/A
- AVG Volume (30 Days)
- VTVT 8.9K
- SCNX 10.3K
- Earning Date
- VTVT 03-12-2025
- SCNX 03-04-2025
- Dividend Yield
- VTVT N/A
- SCNX N/A
- EPS Growth
- VTVT N/A
- SCNX N/A
- EPS
- VTVT N/A
- SCNX 3.55
- Revenue
- VTVT $1,000,000.00
- SCNX N/A
- Revenue This Year
- VTVT N/A
- SCNX $1,085.75
- Revenue Next Year
- VTVT N/A
- SCNX N/A
- P/E Ratio
- VTVT N/A
- SCNX $1.18
- Revenue Growth
- VTVT 11011.11
- SCNX 166.67
- 52 Week Low
- VTVT $8.10
- SCNX $2.61
- 52 Week High
- VTVT $30.99
- SCNX $44.56
- Technical
- Relative Strength Index (RSI)
- VTVT 63.15
- SCNX N/A
- Support Level
- VTVT $19.02
- SCNX N/A
- Resistance Level
- VTVT $20.89
- SCNX N/A
- Average True Range (ATR)
- VTVT 1.15
- SCNX 0.00
- MACD
- VTVT 0.30
- SCNX 0.00
- Stochastic Oscillator
- VTVT 68.18
- SCNX 0.00
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.